CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.

The public appears to have reservations about the integration of artificial intelligence (AI) in US health care, according to a research letter published online July 17 in JAMA Network Open. Moritz ...

Gradient boost model achieves best performance for predicting no-shows and late cancellations in primary care practices.